Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
about
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadSynergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivoAntiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxovirusesMegaRibavirin aerosol for the treatment of influenza A virus infections in miceUse of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.Common community respiratory viruses in patients with cancer: more than just "common colds".Hemodialysis clearance of intravenously administered ribavirin.Safety and pharmacokinetics of rimantadine small-particle aerosol.Pharmacokinetics of ribavirin aerosol in miceActivity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.Respiratory syncytial virus infections.Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosolAntiviral therapy: current concepts and practicesIn vitro and in vivo effects of ribavirin on human respiratory epitheliumClinical pharmacokinetics of inhaled antimicrobials.Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice.Antiviral therapy with small particle aerosols.Biochemistry and clinical applications of ribavirin.Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro.
P2860
Q26822988-03EF82D7-E0E5-4A1F-AF62-120977FD8448Q27477604-051B5A41-FD23-4BA2-AC97-7ECC95906E7AQ28320242-0024F738-59E4-47FD-B785-F749EDE1682EQ30367819-5FE1F12B-BC41-4159-AB61-7A65C2D29DA2Q33979339-2EA12756-73A4-424B-A3DF-CB4B23466EABQ35122262-9D9A8EC5-0CDC-4AD1-930D-5326F018F169Q35251131-1757DF47-0CCC-466F-90DA-5BFCC465EED9Q35282312-FF2490E3-31FF-47A5-875C-A9A029C14BB1Q35289449-59117CC6-04FD-4550-836B-F90630DBE0B6Q35309733-BC653316-3B39-43E4-8DF0-BAC49899A611Q35480437-D5529CD7-A030-4E1E-BE03-CFF55C82CEDDQ35570322-3D33685F-3248-4B6F-B392-14DD5E29525AQ35653947-1327DA2F-9F46-46A0-82D7-C4D003237764Q36070394-40F16D21-1311-4181-8847-3DBCA1F3EBBCQ36215117-2208E48F-7128-49BE-B3DF-E65A01CB49B0Q38367260-0BA9A200-7F26-45F9-B73E-F9684CA01E29Q39178651-E2F77E88-05AF-4595-9FD8-7FCA207EC0ADQ39309529-9D08DB79-6BAE-4694-8620-F29B7BCD3C42Q39460438-64F37505-F08E-4306-BE62-E14DF7A38088Q39818358-039492D7-1C96-4ED4-878A-A91895C2A72E
P2860
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
description
1984 nî lūn-bûn
@nan
1984 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@ast
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@en
type
label
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@ast
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@en
prefLabel
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@ast
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@en
P2093
P2860
P356
P1476
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
@en
P2093
B E Gilbert
H W McClung
J M Quarles
S Z Wilson
P2860
P304
P356
10.1128/AAC.26.2.200
P407
P577
1984-08-01T00:00:00Z